Keywordshypoxia; TNF-α; adenosine; HIF-1α; hippocampus; long-term potentiation; prolyl hydroxylase inhibitor; interleukin-6; astrocyte; EAE; alcohol; ethanol; microglia; cytokines; TNF-alpha; alcoholism; microglial priming; neurodegeneration; Interleukin 13; Interleukin 4; neuron; microglia; Parkinson; brain; neurodegeneration; neuroinflammation; neurotoxic; neuroprotection; pyramidal neurons; Schaffer collaterals; LTP; neuroimmune; alcohol; field potential recordings; cytokine; chemokine; HIV-1; dementia; oligodendrocyte; myelin sheath; restraint stress; chronic ethanol withdrawal; cytokine mRNAs; CRF; alcohol; CP154,526; Parkinson’s disease; neuroinflammation; microglia; fractalkine; astaxanthin; traumatic brain injury; neuroimmunity; neuroinflammation; morphine tolerance; NLRP12 inflammasome; LPS; n/a
